High-resolution characterization of a hepatocellular carcinoma genome
- PMID: 21499249
- DOI: 10.1038/ng.804
High-resolution characterization of a hepatocellular carcinoma genome
Abstract
Hepatocellular carcinoma, one of the most common virus-associated cancers, is the third most frequent cause of cancer-related death worldwide. By massively parallel sequencing of a primary hepatitis C virus-positive hepatocellular carcinoma (36× coverage) and matched lymphocytes (>28× coverage) from the same individual, we identified more than 11,000 somatic substitutions of the tumor genome that showed predominance of T>C/A>G transition and a decrease of the T>C substitution on the transcribed strand, suggesting preferential DNA repair. Gene annotation enrichment analysis of 63 validated non-synonymous substitutions revealed enrichment of phosphoproteins. We further validated 22 chromosomal rearrangements, generating four fusion transcripts that had altered transcriptional regulation (BCORL1-ELF4) or promoter activity. Whole-exome sequencing at a higher sequence depth (>76× coverage) revealed a TSC1 nonsense substitution in a subpopulation of the tumor cells. This first high-resolution characterization of a virus-associated cancer genome identified previously uncharacterized mutation patterns, intra-chromosomal rearrangements and fusion genes, as well as genetic heterogeneity within the tumor.
Comment in
-
Hepatocellular carcinoma enters the sequencing era.Gastroenterology. 2011 Nov;141(5):1943-5. doi: 10.1053/j.gastro.2011.09.027. Epub 2011 Sep 29. Gastroenterology. 2011. PMID: 21963842 Free PMC article. No abstract available.
Similar articles
-
[Oncogenes and suppressor oncogenes in C-type hepatocellular carcinoma].Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):619-23. Nihon Rinsho. 2004. PMID: 15359872 Review. Japanese. No abstract available.
-
Comprehensive genome sequencing of the liver cancer genome.Cancer Lett. 2013 Nov 1;340(2):234-40. doi: 10.1016/j.canlet.2012.10.035. Epub 2012 Nov 8. Cancer Lett. 2013. PMID: 23142287 Review.
-
Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma.Oncology. 2013;84 Suppl 1:93-7. doi: 10.1159/000345897. Epub 2013 Feb 20. Oncology. 2013. PMID: 23428866 Review.
-
Genetic aspects of hepatocellular carcinogenesis.Semin Liver Dis. 1999;19(3):235-42. doi: 10.1055/s-2007-1007113. Semin Liver Dis. 1999. PMID: 10518303 Review.
-
Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.Gastroenterology. 2016 Apr;150(4):998-1008. doi: 10.1053/j.gastro.2015.12.033. Epub 2016 Jan 2. Gastroenterology. 2016. PMID: 26752112
Cited by
-
Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy.J Hepatol. 2015 Nov;63(5):1181-9. doi: 10.1016/j.jhep.2015.06.021. Epub 2015 Jul 2. J Hepatol. 2015. PMID: 26143441 Free PMC article.
-
Therapeutic strategies for hepatocellular carcinoma: new advances and challenges.Curr Treat Options Gastroenterol. 2015 Jun;13(2):219-34. doi: 10.1007/s11938-015-0049-8. Curr Treat Options Gastroenterol. 2015. PMID: 25791207
-
Cancer genome-sequencing study design.Nat Rev Genet. 2013 May;14(5):321-32. doi: 10.1038/nrg3445. Nat Rev Genet. 2013. PMID: 23594910 Review.
-
Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights.World J Gastroenterol. 2014 Mar 28;20(12):3135-45. doi: 10.3748/wjg.v20.i12.3135. World J Gastroenterol. 2014. PMID: 24696599 Free PMC article. Review.
-
Recent advances in bioinformatics reveal the molecular heterogeneity of hepatocellular carcinoma.Liver Cancer. 2014 May;3(2):68-70. doi: 10.1159/000343862. Liver Cancer. 2014. PMID: 24944997 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical